Dr. Umamaheswar Duvvuri on Impact of Multiple Genetic Mutations in Advanced Thyroid Cancer

Video

Umamaheswar Duvvuri, MD, PhD, Assistant Professor of Otolaryngology (ENT) at the University of Pittsburgh Medical Center, talks about potential genetic signatures for locally advanced, well differentiated thyroid cancers.

Umamaheswar Duvvuri, MD, PhD, assistant professor of Otolaryngology (ENT) at the University of Pittsburgh Medical Center, talks about potential genetic signatures for locally advanced, well-differentiated thyroid cancers.

Through the use of next-generation sequencing, it was determined that advanced thyroid cancers are more likely to have multiple mutations than less advanced disease, explains Duvvuri.

Most commonly these advanced cancers seem to have a combination of a BRAF mutation as well as mutation of the promoter region of telomerase reverse transcriptase (hTERT). This may indicate that these two mutations together can cause more aggressive thyroid cancers to form, says Duvvuri.

<<<

View more from the 2015 International Thyroid Congress

Related Videos
Patrick I. Borgen, MD
Anna Lee, MD, MPH
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania